Petrie-Flom Center: Health Law, Biotech and Bioethics

Harvard Law expert Carmel Shachar says if California wins its suit against drug manufacturers, it could make the lifesaving drug more affordable for everyone.

Harvard Law panelists say both exploit how brains process information.

Harvard Law Clinical Professor Robert Greenwald retires after a long career securing health care access for vulnerable populations.

This fall, Harvard Law School showcased the works of faculty, alums, and students at book events throughout the semester.

This article was originally published in the Harvard Gazette. Mexico and Colombia recently legalized abortion in landmark rulings that offer a stark contrast to…

The Petrie-Flom Center hosted ‘Roe in limbo: A town hall on the leaked Dobbs opinion.’

A new Harvard Law initiative examines the legal and ethical aspects of therapeutic psychedelics

Glenn Cohen and Carmel Shachar reflect on the administration’s successes, failures, and agenda for the future.

The new Project on Psychedelics Law and Regulation (POPLAR) at Harvard Law School recently convened a conference on the future of psychedelics law and regulation.

The Petrie-Flom Center at Harvard Law School has announced a new research initiative, the Project on Psychedelics Law and Regulation, to promote safety, innovation, and equity in psychedelics research, commerce, and therapeutics.

Mason Marks, POPLAR project lead and Petrie-Flom senior fellow, explains how the initiative will fill a gap in research on the ethical, legal, and social implications of psychedelics law and policy, and previews some of the initiative’s topics of inquiry.

Knowing that people with disabilities would be especially vulnerable during the pandemic to problems with healthcare access and other issues, the Harvard Law School Project on Disability turned its attention early on to COVID-related initiatives and advocacy.

Health law has become especially timely in this year of COVID-19 vaccines and revitalized Obamacare. But for graduating student Phebe Hong ’21, it’s a passion that began in high school.

I. Glenn Cohen ’03 and Carmel Shachar J.D./M.P.H. ’10 of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics discuss the Biden administration's healthcare agenda.

What are the ramifications of this pandemic year for medical practitioners? And how might the future of health care be shaped by the wounds inflicted on those we entrust with our lives?

On February 11, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School announced the formation of its new advisory board.

Should smoking be among the pre-existing health risks that qualify people for priority access to the COVID-19 vaccine? Harvard Law public health expert Carmel Shachar says the answer is yes. 

The Petrie-Flom Center at Harvard Law School is joining forces with the Solomon Center for Health Law and Policy, its counterpart at Yale Law School, to host a seminar series reflecting on ethical and legal issues raised by the COVID-19 pandemic.